Multi-microarray identifies lower AQP9 expression in adjuvant chemotherapy nonresponders with stage III colorectal cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Letters

• Publication date

  2013-08-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.canlet.2013.04.017PMID 23612070
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer

  2013cited by this paper
• Microarray Analysis of Colorectal Cancer Stromal Tissue Reveals Upregulation of Two Oncogenic miRNA Clusters

  2012cited by this paper
• The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study

  2011cited by this paper
• Gene Expression of Vascular Endothelial Growth Factor A, Thymidylate Synthase, and Tissue Inhibitor of Metalloproteinase 3 in Prediction of Response to Bevacizumab Treatment in Colorectal Cancer Patients

  2011cited by this paper
• Long interspersed nuclear element‐1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype‐negative colorectal cancer

  2011cited by this paper
• Prognostic and predictive value of thymidylate synthase expression in primary colorectal cancer.

  2010cited by this paper
• Global Patterns of Cancer Incidence and Mortality Rates and Trends

  2010cited by this paper
• Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin.

  2010cited by this paper
• Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.

  2010cited by this paper
• CD133 expression predicts for non-response to chemotherapy in colorectal cancer

  2010cited by this paper
• Increased aquaglyceroporin 9 expression disrupts arsenic resistance in human lung cancer cells.

  2009cited by this paper
• NCCN Clinical Practice Guidelines in Oncology: colon cancer.

  2009cited by this paper
• NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

  2009cited by this paper
• Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

  2009cited by this paper
• Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

  2007cited by this paper
• Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan.

  2007cited by this paper
• Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study.

  2007cited by this paper
• Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells.

  2007cited by this paper
• Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles.

  2006cited by this paper
• Involvement of Aquaporin 9 in Osteoclast Differentiation*

  2006cited by this paper
• The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment.

  2005cited by this paper
• Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients.

  2005cited by this paper
• Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.

  2003cited by this paper
• Aquaporin‐9 is expressed in a mucus‐secreting goblet cell subset in the small intestine

  2003cited by this paper
• Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9

  2002cited by this paper
• Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays.

  2000cited by this paper
• Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04.

  1999cited by this paper
• Molecular Characterization of a Broad Selectivity Neutral Solute Channel*

  1998cited by this paper
• Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

  1990cited by this paper

• Loss of SATB2 in colorectal cancer is associated with inferior survival and adverse clinicopathologic features: a meta-analysis

  2025cites this paper
• Aquaporins in colorectal cancer: exploring their role in tumorigenesis, metastasis, and drug response

  2024cites this paper
• The Involvement of Peroxiporins and Antioxidant Transcription Factors in Breast Cancer Therapy Resistance

  2023cites this paper
• New Insights on Drug-Resistant Clinical Isolates of Leishmania infantum-Infected Human Macrophages as Determined by Comparative Transcriptome Analyses

  2022cites this paper
• Clinical value and molecular mechanism of AQGPs in different tumors

  2022cites this paper
• Transcriptomic Analysis in Human Macrophages Infected with Therapeutic Failure Clinical Isolates of Leishmania infantum

  2022cites this paper
• Gene Expression Signature to Predict Prognosis and Adjuvant Chemosensitivity of Colorectal Cancer Patients

  2020cites this paper
• Combined Systematic Review and Transcriptomic Analyses of Mammalian Aquaporin Classes 1 to 10 as Biomarkers and Prognostic Indicators in Diverse Cancers

  2020cites this paper
• Prognostic Role of mRNA-Expression of Aquaporins (AQP) 3, 4, 7 and 9 in Stage pT1 Non-Muscle-Invasive Bladder Cancer

  2020cites this paper
• CMAR_A_243490 3301..3310

  2020cites this paper
• Electrolyte disorders in cancer patients: a systematic review

  2019cites this paper
• Epigenetic Biomarkers in Colorectal Cancer Patients Receiving Adjuvant or Neoadjuvant Therapy: A Systematic Review of Epidemiological Studies

  2019cites this paper
• Aquaglyceroporins: Drug Targets for Metabolic Diseases?

  2018cites this paper
• AQP9-induced cell cycle arrest is associated with RAS activation and improves chemotherapy treatment efficacy in colorectal cancer

  2017cites this paper
• Role of AQP9 in transport of monomethyselenic acid and selenite

  2017cites this paper
• Aquaporins as diagnostic and therapeutic targets in cancer: How far we are?

  2015cites this paper
• MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer

  2015cites this paper
• Ion channel expression as promising cancer biomarker.

  2015cites this paper
• Effects of chemotherapy on global gene expression in non-small cell lung cancer.

  2014cites this paper
• DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma

  2014cites this paper